Join9am
Senior Product Engineer
United States, Remote. Posted 5 months ago
The role
You will design, implement, and operate backend and fullstack systems that incorporate LLMs, tools, and agents. You will work with Product and Design to build agentic workflows and integrate LLMs into production systems.
What you will do
- Design, implement, and operate backend and fullstack systems that incorporate LLMs, tools, and agents
- Build agentic workflows that solve real product and operational problems
- Integrate LLMs safely and reliably into production systems
- Use modern AI coding tools to accelerate development, refactoring, and exploration
- Set patterns and standards for how AI is used in day to day engineering work
- Collaborate with Product Management, Design, and other stakeholders to shape solutions
- Translate high level goals into technical architecture and execution plans
- Contribute to roadmap discussions
- Design APIs, services, and data models
- Ensure reliability, security, privacy, and scalability in a regulated healthcare context
Required qualifications
- 7+ years of experience as a Software Engineer
- Strong knowledge of AWS, Java, Typescript
- Strong experience in building with LLMs in production
- Clear enthusiasm for the capabilities and opportunities of AI and agentic systems
- Strong system design skills
- Comfort working in ambiguous problem spaces
- Ability to communicate clearly with technical and non-technical stakeholders
Nice to have
- Experience designing, building, and operating long running workflows, background jobs, or distributed systems
- Familiarity with healthcare, regulated products, or safety critical systems
- Startup or fast moving product environment experience
Benefits
- Health, dental, and vision insurance
- Flexible PTO
- Work from home options
- Professional development budget
- Support continuing education
About the company
9amHealth is an AI-enabled virtual specialty care platform focused on managing high-cost chronic conditions at scale. The company was founded in 2021 and is backed by leading healthcare investors.